P73 gene alterations and expression in primary oral and laryngeal squamous carcinomas

Carcinogenesis

Volumn 22, Issue 5, 2001, Pages 729-735

  El Naggar, Adel K ^a   Lai, Syeling ^a   Clayman, Gary L ^a   Mims, Betsy ^a   Lippman, Scott M ^a   Coombes, Madelene ^a   Luna, Mario A ^a   Lozano, Guillermina ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P21; PROTEIN P53; PROTEIN P73;

ADULT; AGED; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 1P; CODON; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETICS; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; MOUTH CARCINOMA; MUTATION RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0035030186     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.5.729     Document Type: Article

References (60)

1. DeVesa, S.S., Blot, W.J., Stone, B.J., Miller, B.A., Tarone, R.E. and Fraumeni, J.F. (1995) Recent cancer trends in the United States. J. Natl Cancer Inst., 87, 175-182.
2. Parker, S.L., Tong, T., Bolden, S. and Wingo, P. (1997) Cancer statistics. CA Cancer J. Clin., 47, 5-27.
3. Landis, S.H., Murray, J., Bolden, S. and Wingo, P.A. (1999) Cancer Statistics. CA Cancer J. Clin., 48, 8-31.
4. Snow, G.B. (1989) Evaluation and staging of patients with head and neck cancer. In Myers E.N. and Suen, J.Y. (eds), Cancer of Head and Neck, 2nd Edn. Churchill Livingstone, New York, NY, pp. 17-38.
5. Beckhardt, R.N., Kiyokawa, N., Xi, L., Lie, T.-J., Hung, M.C., El-Naggar, A.K., Zhang, H.-Z. and Clayman, G.L. (1995) HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 121, 1265-1270.
6. Klijanienko, J., El-Naggar, A.K., de Brand, F., Rodriquez-Peralto, J.-L., Rodriquez, R., Itzhaki, M., Russo, A., Janot, F., Luboinski, B. and Cvitkovic, E. (1995) Tumor vascularization, milotic index, histopathologic grade and DNA ploidy in the assessment of 114 head and neck squamous cell carcinoma. Cancer, 75, 1649-1656.
7. Jin, Y.-T., Kayser, S., Kemp, B.L., Ordonez, N.G., Tucker, S.L., Clayman, G.L., Goepfert,H., Luna, M.A., Batsakis, J.G. and El-Naggar, A.K. (1998) The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer, 82, 2159-2165.
8. Ah-See, K.W., Cooke, T.G., Pickford, I.R., Soutar, D. and Balmain, A. (1994) An allelotype of squamous carcinoma of the head and neck using microsatellite marker. Cancer Res., 54, 1617-1621.
9. Califano, C.J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greeberg, B., Kock, W. and Sidransky, D. (1996) Genetic progression model of head and neck cancer: implications for field cancerization. Cancer Res., 56, 2488-2492.
10. El-Naggar, A.K., Hurr, K., Batsakis, J.G., Luna, M.A., Goepfert, H. and Huff, V. (1995) Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res., 5, 2656-2659.
11. Nawroz, H., van der Riet, P., Hruban, R.H., Koch, W., Ruppert, J.M. and Sidransky, D. (1994) Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54, 1152-1155.
12. El-Naggar, A.K., Lai, S., Luna, M.A., Zhou, X.D., Weber, R.S., Goepfert, H. and Batsakis, J.G. (1995) Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous cell carcinoma. Int. J. Cancer. 64, 196-201.
13. Brennan, J.A., Boyle, J.O., Koch, W.M., Goodman, S.N., Hruban, R.H., Eby, Y.J., Cough, M.J., Forastiere, A.A. and Sidransky, D. (1995) Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332, 712-717.
14. Field, J.K., Zoumpourlis, V., Spandidos, D.A. and Jones, A.S. (1994) p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. Cancer Detect. Prev., 18, 197-208.
15. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F. and Caput, D. (1997) Monallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
16. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinato, M. and Ikawa, S. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Med., 4, 839-843.
17. Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J. and Sidransky, D. (1998) A new human p53 homologue. Nature Med., 4, 747-748.
18. Kaelin, W.G (1998) Another p53 Doppelgánger? Science, 281, 57-58.
19. Mori, N., Morosetti, R., Spira, S., Lee, S., Ben-Yehuda, D., Schiller, G., Landolfi, R., Mizoguchi, H. and Koeffler, H.P. (1998) Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood, 92, 3405-3409.
20. Levrero, M., DeLaurenzi, V., Costanzo, A., Sabatini, S. and Gong, J. (2000) The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J. Cell Sci., 113, 1661-1670.
21. White, P.S., Maris, J.M., Sulman, E.P., Jensen, S.J., Kyemba, S.M., Beltinger, C.P., Allen, C., Kramer, D.L., Biegel, J.A. and Brodeur, G.M. (1997) Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. Eur. J. Cancer, 33, 1957-1961.
22. Cunsoio, C.L., Casciano, I., Banelli, B., Tonini, G.P. and Romani, M. (1998) Refined chromosomal localization of the putative tumor suppressor gene TP73. Cytogenet. Cell Genet., 82, 199-201.
23. Onyango, P., Lubyova, B., Gardellin, P., Kurzbauer, R. and Weith, A. (1998) Molecular cloning and expression analysis of five novel genes in chromosome 1p36. Genomics, 50, 187-198.
24. Vance, J.M., Matise, T.C., Wooster, R., Schutte, B.C., Bruns, G.A.P., vanRoy, N., Brodeur, G.M., Tao, Y.X., Gregory, S., Weith, A., Vaudin, M. and White, P. (1997) Report and abstracts of the Third International Workshop on Human Chromosome 1 Mapping 1997. Cytogenet. Cell Genet., 78, 153-182.
25. Dickman, S. (1997) First p53 relative may be a new tumor suppressor. Science, 211, 1605.
26. Kaelin, W.G. (1999) The emerging p53 gene family. J. Natl Cancer Inst., 91, 594-598.
27. Oren, M. (1997) Lonely no more: p53 finds its kin in a tumor suppressor haven. Cell, 90, 829-832.
28. Prives, C. and Hall, P.A. (1999) The p53 pathway. J. Pathol., 187, 112-126.
29. Zaika, A.I., Kovalev, S., Marchenko, N.D. and Moll, U.M. (1999) Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res., 59, 3257-3263.
30. DeLaurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med., 188, 1763-1768.
31. Di Como, C.J., Gaiddon, C. and Prives, C. (1999) p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol., 19, 1438-1449.
32. Zeng, X., Chen, L., Jost, C.A., Maya, R., Keller, D., Wang, X., Kaelin, W.G., Oren, M., Chen, J. and Lu, H. (1999) MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol., 19, 3257-3266.
33. Jost, C.A., Marin, M.C. and Kaelin, W.G (1997) p73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-194.
34. Takahashi, H., Ichimiya, S., Nimura, Y., Watanable, M., Furusato, M., Wakui, S., Yatani, R., Aizawa, S. and Nakagawara, A. (1998) Mutation, allelotyping and transcription analysis of the p73 gene in prostatic carcinoma. Cancer Res., 58, 2076-2077.
35. Marin, M.C., Jost, C.A., DeCaprio, J.A., Caput, D. and Kaelin, W.G. Jr (1998) Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol. Cell. Biol., 18, 6316-6324.
36. Prabhu, N., Somasundaran, K., Satyamoorthy, K., Herlyn, M. and El Deiry, W.S. (1998) P73 beta, unlike p53. suppress growth and induces apoptosis of human papillomavirus E6 expressing cancer cells. Int. J. Oncol., 13, 5-9.
37. Roth, J., Konig, C., Wienzek, S., Weigel, S., Ristea, S. and Dobbelstein, M. (1998) Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoptoteins. J. Virol., 72, 8510-8516.
38. Steegenga, W.T., Shvarts, A., Riteco, N., Bos, J.L. and Jochemsen, A.G. (1999) Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B and E4orf6 proteins. Mol. Cell. Biol., 19, 3885-3894.
39. Chi, S.-G., Chang, S.-G., Lee, S.-J., Lee, C.-H., Kim, J.L. and Park, J.-H. (1999) Elevated and biallelic expression of p73 is associated with progression of human bladder cancer. Cancer Res., 59, 2791-2793.
40. Kovalev, S., Marchenko, N., Swendeman, S., La Quaglia, M. and Moll, U.M. (1998) Expression level, allelic origin and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ., 9, 897-903.
41. Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y.-M. and Nakagawara, A. (1998) P73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer, 78, 437-440.
42. Tsao, H., Zhang, X., Majewski, P. and Haluska, F.G. (1999) Mutational and expression analysis of the p73 gene in melanoma cell lines. Cancer Res., 59, 172-174.
43. Yokomizo, A., Mai, M., Bostwick, D.G., Tindall, D.J., Qian, J., Cheng, L., Jenkins, R.B., Smith, D.I. and Liu, W. (1999) Mutation and expression analysis of the p73 gene in prostate cancer. Prostate, 39, 94-100.
44. Zaika, A.I., Sovalev, S., Marchenko, N.D. and Moll, U.M. (1999) Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res., 59, 3257-3263.
45. Cai, Y.C., Yang, G.-Y., Nie, Y., Wang, L.-D., Zhao, X., Song, Y.-L., Seri, D.N., Liao, J., Xing, E.P. and Yang, C.S. (2000) Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis, 21, 683-689.
46. Deng, W.P. and Nickoloff, J.A. (1992) Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem., 200, 81-88.
47. Banelli, B., Casciano, I. and Romani, M. (2000) Methylation silencing of the p73 gene in neuroblastoma. Oncogene, 19, 4553-4556.
48. Perri, P. Praml, C., Savelyeva, L., Pillmann, A. and Schwab, M. (1999) Fine mapping of distal lp loci reveals tp73 at DIS468. Cytogenet. Cell Genet., 84, 111-114.
49. Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., Kaneko, Y., McKeon, F., Caput, D. and Nakagawara, A. (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene, 18, 1061-1066.
50. Mai, M., Huang, H., Reed, C., Qian, C., Smith, J.S., Alderete, B., Jenkins, R., Smith, D.I. and Liu, W. (1998) Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics, 51, 359-363.
51. Mai, M., Yokomizo, A., Qian, C., Yang, P., Tindall, D.J., Smith, D.I. and Liu, W. (1998) Activation of p73 silent allele in lung cancer. Cancer Res., 58, 2347-2349.
52. Takada, N., Ozaki, T., Ichimiga, S., Todo, S. and Nakagawara, A. (1999) Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res., 59, 2810-2814.
53. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T. and Takahashi, T. (1998) Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383.
54. Sunahara, M., Ichimiya, S., Nimura, Y., Takada, N., Sakiyama, S., Sato, Y., Todo, S., Adachi, W., Amano, J. and Nakagawara, A. (1998) Mutational analysis of the p73 gene localized al chromosome 1p36.3 in colorectal carcinoma. Int. J. Oncol., 13, 319-323.
55. Mai, M., Qian, C., Yokomizo, A., Tindall, D.J., Bostwick, D., Polychronakos, C., Smith, D.I. and Liu, W. (1998) Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene, 17, 1739-1741.
56. Yokomizo, A., Mai, M., Tindall, D.J., Cheng, L., Bostwick, D.G., Naito, S., Smith, D.I. and Liu, W. (1999) Overexpression of the wild type p73 gene in human bladder cancer. Oncogene, 18, 1629-1633.
57. Senoo, M., Seki, N., Ohira, M., Sugano, S., Watanable, M., Inuzuka, S., Okamoto, T., Tachibana, M., Tanaka, T., Shinkai, Y. and Kato, H. (1998) A second p53-related protein, p74L, with high homology to p73. Biochem. Biophys. Res. Commun., 248, 603-307.
58. Kong, X.-T., Valentine, V.A., Rowe, S.T., Valentine, M.B., Ragsdale, S.T., Jones, B.G., Wilkinson, D.A., Brodeur, G.M., Cohn, S.L. and Look, A.T. (1999) Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and cell lines. Neoplasia, 1, 80-89.
59. El-Naggar, A.K., Lai, S., Clayman, G., Lee, J.K., Luna, M.A., Goepfert, H. and Batsakis, J.G. (1997) Methylation: a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am. J. Pathol., 151, 1767-1774.
60. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P.J., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.